Major Depressive Disorder and Management of Population Health

Major Depressive Disorder and Management of Population Health

Release date: July 23, 2018
Expiration date: July 23, 2019
Target audience: Physicians, pharmacists, and managed care professionals
Type of activity: Application
Length of podcast: 1 hour
Fee: Free

Activity Overview
The behavioral health care landscape is evolving and healthcare professionals are becoming more aware of the need to improve patient care and adherence to treatment. This activity examines the prevalence of major depressive disorder and the diversity of treatment options. The role played by accountable care organizations in helping to enhance the quality of life of patients experiencing this condition will also be highlighted.
Educational Objectives
Determine the prevalence of depression while describing the disparities in care and disabilities associated
Illustrate prohibitive treatment modalities that exist within major depressive disorder and how accountable care organizations are working to improve patient care
Apply the successes and failures of depression treatment within the private and public sectors, including how adherence to medications is being addressed
https://ptce.s3.amazonaws.com/_media/_eblast/ACPE_Large.jpgPharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number UAN is 0290-0000-18-134-H01-P. The activity is available for CE credit through July 23, 2019.

This activity is supported by an educational grant from Takeda.
How to Obtain Credit
To receive credit, participants must complete the online pretest, listen to the podcast in its entirety, and complete the online posttest and activity evaluation form. After completing the online assessment tests and activity evaluation form, participants may request credit. All participants must request credit before July 23, 2019. CE credit will not be issued after this date.

Disclosures
Faculty
Roger Kathol, MD, has the following relevant financial relationship with a commercial interest to disclose:
Consultant/Stock-Shareholder: Cartesian Solutions, Inc.
The following contributors have no relevant financial relationships with commercial interests to disclose:

Pharmacy Times Continuing Education™
Planning Staff – Dave Heckard; Maryjo Dixon, RPh; Katie Pierson; and Susan Pordon

An anonymous peer reviewer has been used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

The content of this podcast may include information regarding the use of products that may be inconsistent with, or outside the approved labeling for, these products in the United States. Pharmacists should note that the use of these products outside current approved labeling is considered experimental and are advised to consult the prescribing information for these products.
Educational Disclaimer
Continuing professional education (CPE) activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.